Myofibrils
发表于 2025-3-28 15:04:13
http://reply.papertrans.cn/23/2220/221912/221912_41.png
Campaign
发表于 2025-3-28 22:30:00
Hypertension in CoViD19,d blood pressure adversely impacts CoViD19 patients. The behavior of hypertension, phenotypical characteristics, and trends lack clarity in data and remain poorly understood. Although mounting evidence supports CoViD19 and hypertension interlinks, the evidence base needs to be further examined and s
周年纪念日
发表于 2025-3-29 01:53:24
http://reply.papertrans.cn/23/2220/221912/221912_43.png
Factual
发表于 2025-3-29 06:54:50
Acute Coronary Syndromes in CoViD19, (ACS) are among the most critical CoViD19 complications that display a high potential for lethality and prospective risks. Although a decline has been observed in the hospital admissions due to the ACS and in coronary interventions during the CoViD19 pandemic, the association of the ACS observed wi
壮观的游行
发表于 2025-3-29 08:15:38
http://reply.papertrans.cn/23/2220/221912/221912_45.png
煞费苦心
发表于 2025-3-29 11:49:12
Obesity and COVID19,hed a pandemic level. Adipose tissue is no longer considered a structural support element of the body, but a complex organ with a diversity of metabolic, endocrine, and immune related functions, and is a potent risk factor. The risks and comorbidities associated with obesity and correlated condition
Esophagus
发表于 2025-3-29 19:08:58
http://reply.papertrans.cn/23/2220/221912/221912_47.png
Jogging
发表于 2025-3-29 23:23:39
http://reply.papertrans.cn/23/2220/221912/221912_48.png
多骨
发表于 2025-3-30 00:30:28
The Epidemiology of CoViD19 and Cardiovascular Diseases,ion, arrhythmias, and death. We explore the epidemiological evidence base of these complications and the risk factors and investigate whether the pre-existing cardiovascular diseases promote cardiovascular complications in CoViD19 or the infection triggers the development of these complications. A b
bioavailability
发表于 2025-3-30 04:02:08
http://reply.papertrans.cn/23/2220/221912/221912_50.png